VBIV

VBI Vaccines, Inc.

0.70 USD

Last updated Dec 11, 21:51 UTC

Yesterday HIGH

$0.72

Yesterday LOW

$0.69

52w HIGH

$21

52w LOW

$0.45

EPS

-0.38

PE

-1.84

Next Earnings

Mar 11, 2024

Overview News Government Trades

VBI Vaccines, Inc. stock is up 16.23% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 7 December’s closed higher than November.

VBI Vaccines Inc. develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for chronic HBV infection.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Cambridge, United States Of America

Website

www.vbivaccines.com

Happy Mohamed

Thu Jul 6, 2023

VBI Vaccines Announces Pricing Of $18M Public Offering And $3M Concurrent Registered Direct Offering

Approximately $21 million in gross proceeds from underwritten public offering and concurrent registered direct offering add to upfront payment from Brii Biosciences for a combined $33 million to be
Lisa Levin

Thu Jul 6, 2023

Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket

Gainers Akumin Inc. (NASDAQ: AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company.
Vandana Singh

Thu Jul 6, 2023

VBI Vaccines, Brii Biosciences Expand Hepatitis B Immunotherapy Pact

VBI Vaccines Inc (NASDAQ: VBIV) expanded its hepatitis B (HBV) partnership with Brii Biosciences to work on
Lisa Levin

Thu Jul 6, 2023

Levi Strauss, VBI Vaccines And 3 Stocks To Watch Heading Into Thursday

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Benzinga Newsdesk

Wed Jul 5, 2023

VBI Vaccines Plans Proposed Concurrent Public Offering And Registered Direct Offering Of Common Shares, Warrants; Terms Not Disclosed

BI also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of common shares and/or common warrants offered in the public offering.
Benzinga Newsdesk

Wed Jul 5, 2023

VBI Vaccines And Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention And Treatment In License And Collaboration Agreements For Up To $437M Plus Royalties

Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri® in the Asia Pacific regionVBI will receive gross proceeds of $15 million in upfront payments, subject to
Lisa Levin

Mon Jul 3, 2023

Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Session

Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share.
Lisa Levin

Mon Jul 3, 2023

US Stocks Mixed; Dow Falls Over 50 Points

U.S. stocks traded mixed this morning, with the Dow Jones dropping more than 50 points on Monday. Following the market opening Monday, the Dow traded down 0.19% to 34,341.91 while the NASDAQ rose 0.28% to 13,827.05. The S&P 500, also fell, dropping, 0.02% to 4,449.70.
Lisa Levin

Mon Jul 3, 2023

Why Tattooed Chef Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket

Gainers Micromobility.com Inc. (NASDAQ: MCOM) shares surged 60% to $0.18 in pre-market trading. micromobility.com recently reported a strategic realignment to strengthen its financial position and drive profitability.
Benzinga Newsdesk

Fri Jun 30, 2023

VBI Vaccines Wins $25.35M Contract From Department Of Health And Human Services For '2023 Adult Vaccines'

https://sam.gov/opp/ac9168e365d242458f9a1b5138875052/view